Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Monthly Archives: October 2014

NJ Chamber of Commerce Honors State’s Greatest Innovators, Innovations

Trenton, NJ, October 29, 2014 NJBIZ reports that at the New Jersey Chamber of Commerce Innovation Gala held Monday in Somerset, the chamber revealed its picks for the 25 greatest innovators in New Jersey history as part of the celebration of the state’s 350th anniversary.

Some of the names are familiar to every American, and some only to those who study their particular field.  But everyone on the list compiled by the chamber in conjunction with NJBIZ is a star in the field of invention. Continue reading

NJLSVA to Host Annual Procurement Conference on Oct. 28 at Rowan University

Register Here SquareNew Brunswick, NJ, October 22, 2014 ― You are invited to attend the New Jersey Life Sciences Vendors Alliance (NJLSVA) Annual Procurement Conference on Tuesday, October 28 in Rowan Hall at Rowan University, 201 Mullica Hill Road in Glassboro, NJ.  Admission is free.

A continental breakfast and networking will begin at 8:00 a.m., and the program will run from 8:45 a.m. to 12:30 p.m.

The conference agenda will include:

  • Pharmaceutical industry executives who will speak on the latest trends in procurement;
  • A presentation on how the new Rowan University can help attendees’ businesses;
  • An update from Trenton and Washington, D.C. on current issues impacting New Jersey’s life sciences community Continue reading

Governor Christie Activates Statewide Ebola Preparedness Plan

Trenton, NJ, October 22, 2014 ― Today, Governor Chris Christie signed Executive Order 164 creating the Ebola Virus Disease Joint Response Team (EVD-JRT) that will direct and coordinate on all matters pertaining to New Jersey’s public health response.

Christie administration officials, state agencies and departments will work in a coordinated manner to ensure the health and safety of New Jersey residents is protected and to execute on decisions in an efficient and effective manner.

The EVD-JRT will also form an advisory panel of additional administration entities, as well as representatives from the medical community. Continue reading

R&D Council’s Cicatiello on Long-Term Data Protection Critical for Future of NJ’s Biotech Sector

Newark, NJ, October 20, 2014 Writing in today’s Star-Ledger, Anthony S. Cicatiello, president of the Research & Development Council of New Jersey, writes:

A trade deal being brokered thousands of miles from New Jersey could have a profound effect on our state’s financial future.

Representatives from the United States and other Pacific-Rim countries will meet in Australia this month to continue negotiations on a major new international free-trade agreement. The Trans-Pacific Partnership is expected to foster trade among the United States and some of the major economies of the Asia-Pacific region, including Australia, Japan and New Zealand.

But in order to complete the deal, negotiators will have to come to agree on a number of vexing issues. One especially important to the New Jersey economy is protection of intellectual property. A key sector of our economy could be fatally undermined if U.S. negotiators don’t stand firm. Continue reading

PhRMA Launches Website to Educate Consumers on ABCs of Health Coverage, Prescription Access

Washington, DC, October 15, 2014 ― The Pharmaceutical Research and Manufacturers of America (PhRMA) has launched Access Better Coverage.org, a new website designed to educate consumers about the ABCs of health coverage and access to prescription medicines.

The new site introduces important resources to help people better understand how health insurance works and what to expect from their coverage, including a series of white board videos explaining basic insurance terms like deductibles, copays and coinsurance, and how formularies and tiers work. Continue reading

COMMERCE Magazine Interviews HINJ’s Paranicas on NJ’s Life Sciences Community

Paramus, NJ, October 13, 2014 ― The October issue of Commerce magazine includes an interview with HINJ President and Chief Executive Officer Dean J. Paranicas on the state of New Jersey’s life sciences sector.

To read the Paranicas interview, turn to page 76 in the digital magazine. Continue reading

COMMERCE Magazine Interviews HINJ’s Paranicas on NJ’s Life Sciences Community

 Paramus, NJ, October 13, 2014 ― The October issue of Commerce magazine includes an interview with HINJ President and Chief Executive Officer Dean J. Paranicas on the state of New Jersey’s life sciences sector.

To read the Paranicas interview, turn to page 76 in the digital magazine.

Founded in 1997, the HealthCare Institute of New Jersey (HINJ) serves as the voice for the state’s life sciences industry.  HINJ seeks to expand patient access to the most innovative biopharmaceuticals and medical devices and promote awareness of the industry’s impact on New Jersey’s quality of life and economic well-being.  In 2012, HINJ member companies’ economic impact in the state exceeded $26 billion, according to HINJ’s 2013 Economic Impact Report.  To learn more, please visit HINJ at www.hinj.org or follow us via Twitter @ HINJ_ORG, Facebook @ HealthCareInstituteofNewJersey or YouTube @HINJNJ.

At Life Sciences Celebration, HINJ Honors Rep. Rush Holt, Dr. Joachim Kohn, Students 2 Science and Leukemia & Lymphoma Society’s NJ Chapter

New Brunswick, NJ, October 9, 2014 ― The HealthCare Institute of New Jersey (HINJ) last evening honored two New Jersey leaders and two organizations for their contributions in public service, life sciences research, STEM (science, technology, engineering and mathematics) education and patient advocacy.

The awards were presented at HINJ’s Life Sciences Celebration 2014, which was held at the Renaissance Woodbridge Hotel in Iselin.

Those recognized were Congressman Rush Holt (D-NJ-12); Joachim Kohn, Ph.D., FBSE, Director, New Jersey Center for Biomaterials, and Board of Governors Professor of Chemistry, Rutgers, The State University of New Jersey; Students 2 Science, Inc.; and The Leukemia & Lymphoma Society’s New Jersey Chapter. Continue reading

PhRMA Report: Nearly 800 New Medicines in Development to Help Combat Cancer

Washington, DC, October 7, 2014 ― America’s biopharmaceutical research companies are currently developing nearly 800 new medicines and vaccines for cancer, according to a new report released yesterday by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Cancer is the second leading cause of death in the United States, accounting for nearly one of every four deaths, according to the American Cancer Society.  More than 1.6 million new cancer cases will be diagnosed in 2014 alone and nearly 600,000 Americans are projected to die from cancer this year.

As detailed in the new report, biopharmaceutical research companies continue to explore new avenues to fight cancer, which has been found to be a set of more than 200 unique diseases.   Continue reading

NJ Chamber’s Gala for Innovation and NJ’s 350th Anniversary Set for October 27

Trenton, NJ, October 6, 2014 ― When the New Jersey Chamber of Commerce throws a party, we do it right. That’s why you need to join us at The Palace in Somerset on Monday evening, October 27 as it celebrates New Jersey’s 350th Anniversary.  Click here to register.

The Chambers’ special guests will include:

  • Lt. Gov. Kim Guadagno
  • The families of Thomas Edison and Selman Waksman, Rutgers’ Nobel Prize-wining “Father of Antibiotics”
  • Heads of the state’s most prestigious R&D firms
  • Dignitaries from the Isle of Jersey, the birthplace of our state’s name
  • Chemical engineer John J. Mooney, whose invention of the three-way catalytic converter landed him at No. 17 on our list of the Top 25 innovators in New Jersey history Continue reading